Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 259

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin

Open access
YEOMANS, N. D., LANAS, A. I., TALLEY, N. J., THOMSON, A. B. R., DANESHJOO, R., ERIKSSON, B., APPELMAN‐ESZCZUK, S., LÅNGSTRÖM, G., NAESDAL, J., SERRANO, P., SINGH, M., SKELLY, M. M., HAWKEY, C. J.·2005·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background : Aspirin is valuable for preventing vascular events, but information about ulcer frequency is necessary to inform risk‐benefit decisions in individual patients. Aim : To determine ulcer prevalence and incidence in a population representative of those given aspirin therapy and evaluate risk predictors. Methods : Patients taking aspirin 75–325 mg daily were recruited from four countries. Exclusions included use of gastroprotectant drugs or other non‐steroidal anti‐inflammatory drugs. We measured point prevalence of endoscopic ulcers, after quantitating dyspeptic symptoms. Incidence was assessed 3 months later in those eligible to continue (no baseline ulcer or reason for gastroprotectants). Results : In 187 patients, ulcer prevalence was 11% [95% confidence interval (CI) 6.3–15.1%]. Only 20% had dyspeptic symptoms, not significantly different from patients without ulcer. Ulcer incidence in 113 patients followed for 3 months was 7% (95% CI 2.4–11.8%). Helicobacter pylori infection increased the risk of a duodenal ulcer [odds ratio (OR) 18.5, 95% CI 2.3–149.4], as did age >70 for ulcers in stomach and duodenum combined (OR 3.3, 95% CI 1.3–8.7). Conclusions : Gastroduodenal ulcers are found in one in 10 patients taking low‐dose aspirin, and most are asymptomatic; this needs considering when discussing risks/benefits with patients. Risk factors include older age and H. pylori (for duodenal ulcer).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2005.02649.x

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 259

Metadata

Authors
YEOMANS, N. D., LANAS, A. I., TALLEY, N. J., THOMSON, A. B. R., DANESHJOO, R., ERIKSSON, B., APPELMAN‐ESZCZUK, S., LÅNGSTRÖM, G., NAESDAL, J., SERRANO, P., SINGH, M., SKELLY, M. M., & HAWKEY, C. J.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2005-10-14
Volume
22
Issue
9
Pages
795-801
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2012484960
Cited by
259
References
28
FWCI
6.36
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. https://app.cochat.ai/papers/10.1111/j.1365-2036.2005.02649.x
The paper
YEOMANS, N. D., LANAS, A. I., TALLEY, N. J., THOMSON, A. B. R., DANESHJOO, R., ERIKSSON, B., APPELMAN‐ESZCZUK, S., LÅNGSTRÖM, G., NAESDAL, J., SERRANO, P., SINGH, M., SKELLY, M. M., & HAWKEY, C. J. (2005). Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2005.02649.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.